Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
- PMID: 38598587
- DOI: 10.1056/NEJMc2401277
Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Comment on
-
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous